Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis
- PMID: 21691937
- DOI: 10.1007/s10875-011-9555-1
Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis
Abstract
Objective: This case-controlled study was designed to correlate urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and interleukin-8 (IL-8) levels, with renal involvement in a cohort of systemic lupus erythematosus (SLE) patients to examine their diagnostic performance.
Patients and methods: In 73 SLE patients, and in 23 healthy volunteers, urinary levels of TWEAK, OPG, MCP-1, and IL-8 levels were measured. Disease activity was assessed by total SLE disease activity index, and renal activity by renal activity index (rSLEDAI), and both were correlated with urinary biomarkers. Sensitivity, specificity, and predictive values of individual biomarkers to predict lupus nephritis were also calculated.
Results: Significantly higher levels of urinary biomarkers were observed in SLE patients with lupus nephritis (LN) compared with those without LN (TWEAK, p < 0.001; MCP-1, p < 0.001; OPG, p < 0.001; IL-8, p < 0.032). Other significantly higher levels were observed in SLE patients with LN compared with control subjects (TWEAK, MCP-1, OPG, and IL-8 p < 0.001). Positive correlations were observed between rSLEDAI and TWEAK (r = 0.612 and p < 0.001), MCP-1 (r = 0.635 and p < 0.001), and OPG (r = 0.505 and p < 0.001).
Conclusions: Urinary levels of TWEAK, OPG, and MCP-1 positively correlate with renal involvement as assessed by rSLEDAI with reasonable sensitivity, specificity, and predictive values to detect lupus nephritis while IL-8 was not significantly associated with global or rSLEDAI.
Similar articles
-
Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis.Ren Fail. 2021 Dec;43(1):20-31. doi: 10.1080/0886022X.2020.1853568. Ren Fail. 2021. PMID: 33307926 Free PMC article.
-
Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.Lupus. 2020 Apr;29(4):379-388. doi: 10.1177/0961203320904997. Epub 2020 Feb 10. Lupus. 2020. PMID: 32041504
-
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.Arthritis Res Ther. 2009;11(5):R143. doi: 10.1186/ar2816. Epub 2009 Sep 28. Arthritis Res Ther. 2009. PMID: 19785730 Free PMC article.
-
Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.J Rheumatol. 2009 Oct;36(10):2224-30. doi: 10.3899/jrheum.081112. Epub 2009 Jul 31. J Rheumatol. 2009. PMID: 19648301
-
Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis.Inflamm Res. 2012 Apr;61(4):277-84. doi: 10.1007/s00011-011-0420-8. Inflamm Res. 2012. PMID: 22297307 Review.
Cited by
-
Role of TWEAK in lupus nephritis: a bench-to-bedside review.J Autoimmun. 2012 Sep;39(3):130-42. doi: 10.1016/j.jaut.2012.05.003. Epub 2012 Jun 22. J Autoimmun. 2012. PMID: 22727560 Free PMC article. Review.
-
Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis.Ren Fail. 2021 Dec;43(1):20-31. doi: 10.1080/0886022X.2020.1853568. Ren Fail. 2021. PMID: 33307926 Free PMC article.
-
Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients.Arthritis Res Ther. 2011;13(5):R175. doi: 10.1186/ar3500. Epub 2011 Oct 25. Arthritis Res Ther. 2011. PMID: 22027240 Free PMC article.
-
TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic.Front Immunol. 2013 Dec 23;4:473. doi: 10.3389/fimmu.2013.00473. Front Immunol. 2013. PMID: 24391646 Free PMC article.
-
TWEAK and the progression of renal disease: clinical translation.Nephrol Dial Transplant. 2014 Feb;29 Suppl 1(Suppl 1):i54-i62. doi: 10.1093/ndt/gft342. Nephrol Dial Transplant. 2014. PMID: 24493870 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous